fluorodeoxyglucose f18 has been researched along with Humeral Fractures in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boyer, A; Jahnwar, YS; Lane, JM; Marty, E; Niesvizky, R; Or, O; Saiyed, R | 1 |
| Ahlman, MA; Grayson, PC; Hughes, M; Malayeri, AA; Newman, KA; Pratt, D | 1 |
2 other study(ies) available for fluorodeoxyglucose f18 and Humeral Fractures
| Article | Year |
|---|---|
Prediction of Long Bone Fractures in Multiple Myeloma Patients in an Advanced Imaging World.
Topics: Biopsy; Bone Marrow; Cortical Bone; Female; Femoral Fractures; Fluorodeoxyglucose F18; Fracture Fixation; Humans; Humeral Fractures; Israel; Male; Middle Aged; Multiple Myeloma; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Risk Assessment | 2021 |
Diagnosis of Giant Cell Arteritis in an Asymptomatic Patient.
Topics: Aftercare; Aged; Antineoplastic Combined Chemotherapy Protocols; Aorta; Asymptomatic Diseases; Cyclophosphamide; Doxorubicin; Etoposide; Fluorodeoxyglucose F18; Fractures, Spontaneous; Giant Cell Arteritis; Humans; Humeral Fractures; Incidental Findings; Lymphoma, Large B-Cell, Diffuse; Magnetic Resonance Angiography; Male; Positron-Emission Tomography; Prednisone; Radiopharmaceuticals; Rituximab; Subclavian Steal Syndrome; Temporal Arteries; Vincristine | 2016 |